Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia. [electronic resource]
Producer: 20101025Description: 1073-80 p. digitalISSN:- 1432-0584
- Adult
- Aged
- Aged, 80 and over
- Anemia, Hemolytic, Autoimmune -- drug therapy
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Female
- Hemoglobins -- metabolism
- Humans
- Immunologic Factors -- therapeutic use
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Remission Induction
- Retrospective Studies
- Rituximab
- Spain
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.